Sera Prognostics Inc - Ordinary Shares Class A

NASDAQ:SERA  
10.17
+0.82 (+8.77%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)312.21M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.08 Million
Adjusted EPS-$0.25
See more estimates
10-Day MA$9.12
50-Day MA$10.34
200-Day MAN/A
See more pivots

Sera Prognostics Inc - Ordinary Shares Class A Stock, NASDAQ:SERA

2749 East Parleys Way, Suite 200, Salt Lake City, Utah 84109
United States of America
Phone: +1.801.990.0520
Number of Employees: 59

Description

Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.